GIND: Goldman Sachs India Equity ETF
Understanding the Goldman Sachs India Equity ETF (GIND)
The Goldman Sachs India Equity ETF (ticker: GIND) is an exchange-traded fund designed to provide exposure to the Indian equity market. It holds a variety of companies, primarily focusing on large businesses in India.
What this ETF is trying to do
This ETF seeks to track the performance of companies in India. By holding many different stocks, it allows investors to gain access to the Indian stock market through a single fund. The fund currently holds 129 different assets.
Top Holdings
The following is a partial list of the largest companies held by the fund. Please note that holdings can change over time:
• ICICI BANK LTD (5.32%)
• HDFC BANK LTD (3.36%)
• RELIANCE INDUSTRIES LTD (2.81%)
• AXIS BANK LTD (2.51%)
• MAHINDRA & MAHINDRA LTD (2.42%)
• KOTAK MAHINDRA BANK LTD (2.18%)
• BAJAJ FINANCE LTD (2.04%)
• ETERNAL LTD (1.95%)
• SUN PHARMACEUTICALS INDUSTRIES LTD (1.87%)
• DIVI'S LABORATORIES LTD (1.77%)
What the numbers show
The data shows that the share price of GIND has declined recently.
• Price Return: This measures only the change in the share price. The year-to-date (YTD) price return is approximately -11.10%, and the one-year price return is approximately -10.14%.
• Total Return: This includes both the share price changes and any distributions paid out. The YTD total return is approximately -10.45%, and the one-year total return is approximately -9.49%.
• Price Comparison: The current price is $23.48. An estimated price from roughly one year ago was approximately $26.13.
Income and distribution explanation
Some investors look at ETFs for regular cash payments, known as distributions. GIND has a distribution yield of approximately 0.74%. This number describes the cash distributions relative to the ETF price.
It is important to remember that a distribution yield is not the same as total return. The fund's distributions are described as "irregular" or "less frequent," with only one payout recorded in the last 12 months.
NAV erosion explanation
"NAV erosion" refers to a decline in the Net Asset Value (the actual value of the assets held by the fund).
The supplied data is sufficient to evaluate price erosion, but it does not include enough historical NAV-per-share data to confirm or rule out NAV erosion. However, the fund has an erosion-risk score of 75, which is labeled as "Mild price erosion." This means the market price has shown some downward movement.
Pros
• Provides diversified exposure to many different Indian companies through a single ticker.
• Includes major players in sectors like banking and pharmaceuticals.
Cons
• The fund has experienced a share-price decline over the last year.
• Distributions are infrequent and the yield is relatively low.
Beginner takeaway
GIND is an ETF that focuses on Indian stocks. While it provides access to a large market, recent data shows the share price has decreased. When looking at this ETF, it is important to distinguish between the price return (the change in share price) and the total return (which includes distributions). High yields can sometimes be misleading, so always look at the total return to see how the fund is performing overall.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | ICICI BANK LTD | n/a | 5.32% |
| 2 | HDFC BANK LTD | n/a | 3.36% |
| 3 | RELIANCE INDUSTRIES LTD | n/a | 2.81% |
| 4 | AXIS BANK LTD | n/a | 2.51% |
| 5 | MAHINDRA & MAHINDRA LTD | n/a | 2.42% |
| 6 | KOTAK MAHINDRA BANK LTD | n/a | 2.18% |
| 7 | BAJAJ FINANCE LTD | n/a | 2.04% |
| 8 | ETERNAL LTD | n/a | 1.95% |
| 9 | SUN PHARMACEUTICALS INDUSTRIES LTD | n/a | 1.87% |
| 10 | DIVI'S LABORATORIES LTD | n/a | 1.77% |